Established in 1937, Duke’s Neuro-Oncology Program is one of the oldest and largest brain tumor research and clinical programs in the United States. Its ongoing expansion and prosperity is due in large part to its affiliation with the Duke Cancer Institute—an NCI-designated cancer institute that links phenomenal patient care and cutting-edge research into one seamless continuum—and, of course, the program members. The 38 members fill full, associate, and secondary positions, in which each position is granted differing levels of access to the DCI’s shared resources. The DCI Neuro-Oncology Program’s all-star team is at the vanguard of brain tumor research, with each member harboring the common goal of providing the best possible treatment for adults and children battling brain or spinal cord tumors.